SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., a fast-growing market leader in the treatment of spinal diseases, today announced the completion of the first European commercial cases with the STAR™ Tumor Ablation System for the palliative treatment of painful metastatic spinal tumors since the device received CE Mark approval last month.
Help employers find you! Check out all the jobs and post your resume.
